SYNTHETIC BIOLOGY and ITS POTENTIAL IMPLICATIONS for BIOTRADE and ACCESS and BENEFIT-SHARING ©2019, United Nations Conference on Trade and Development

Total Page:16

File Type:pdf, Size:1020Kb

SYNTHETIC BIOLOGY and ITS POTENTIAL IMPLICATIONS for BIOTRADE and ACCESS and BENEFIT-SHARING ©2019, United Nations Conference on Trade and Development UNITED NATIONS CONFERENCE ON TRADE AND DEVELOPMENT SYNTHETIC BIOLOGY AND ITS POTENTIAL IMPLICATIONS FOR BIOTRADE AND ACCESS AND BENEFIT-SHARING ©2019, United Nations Conference on Trade and Development. All rights reserved. The trends, figures and views expressed in this publication are those of UNCTAD and do not necessarily represent the views of its member States. The designations employed and the presentation of material on any map in this work do not imply the expression of any opinion whatsoever on the part of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. This study can be freely cited provided appropriate acknowledgment is given to UNCTAD. For further information on UNCTAD’s BioTrade Initiative please consult the following website: http://www.unctad. org/biotrade or contact us at: [email protected] This publication has not been formally edited. UNCTAD/DITC/TED/INF/2019/12 AND ITS POTENTIAL IMPLICATIONS FOR BIOTRADE AND ACCESS AND BENEFIT-SHARING iii Contents Acknowledgements ................................................................................................................................iv Abbreviations ...........................................................................................................................................v EXECUTIVE SUMMARY ............................................................................................. vi SECTION 1: INTRODUCTION TO BIOTRADE, SYNTHETIC BIOLOGY AND SYNTHETIZATION . 1 1. BioTrade ............................................................................................................................................ 1 2. Defining synthetic biology .................................................................................................................. 2 3. Synthetic biology approaches ............................................................................................................ 4 Genome engineering ................................................................................................................... 4 Metabolic engineering ................................................................................................................. 5 Implications for BioTrade and ABS .............................................................................................. 5 4. The difference between chemical synthesis and biosynthesis .......................................................... 6 Chemical synthesis ..................................................................................................................... 6 Biosynthesis ................................................................................................................................ 6 Implications for BioTrade and ABS .............................................................................................. 7 SECTION 2: CASE STUDIES ON NATURAL PRODUCTS, SYNTHESIZATION AND SYNTHETIC BIOLOGY ............................................................................................................ 8 1. Flavours and fragrances .................................................................................................................... 8 Vanilla ......................................................................................................................................... 8 Patchouli ................................................................................................................................... 10 Orange ...................................................................................................................................... 10 Stevia ....................................................................................................................................... 10 2. Pharma and phytopharmaceuticals ................................................................................................. 12 Artemisinin ................................................................................................................................ 12 SECTION 3: LAW AND POLICY ISSUES AT THE INTERFACE OF BIOTRADE AND SYNTHETIC BIOLOGY .......................................................................................................... 14 1. Food labelling .................................................................................................................................. 14 United States ............................................................................................................................ 14 European Union ........................................................................................................................ 14 2. Cosmetic products .......................................................................................................................... 15 United States ............................................................................................................................ 15 European Union ........................................................................................................................ 15 3. Voluntary certification ....................................................................................................................... 16 Non-GMO certification .............................................................................................................. 16 COSMOS .................................................................................................................................. 16 NATRUE.................................................................................................................................... 16 SECTION 4: CONCLUSIONS ON IMPLICATIONS OF SYNTHETIC BIOLOGY FOR BIOTRADE AND ABS ......................................................................................................... 18 1. General conclusions on possible implications of SynBio for BioTrade ............................................... 18 2. Potential implications of SynBio for ABS .......................................................................................... 20 3. Recommendations on the way forward for BioTrade ........................................................................ 20 iv SYNTHETIC BIOLOGY ANNEX I:DEFINITIONS OF SYNTHETIC BIOLOGY ......................................................... 24 ANNEX II: SELECTED SYNTHETIC BIOLOGY TOOLS AND TECHNIQUES .......................... 25 1. BioBrick engineering ........................................................................................................................ 25 2. Bioinformatics .................................................................................................................................. 25 3. Design tools .................................................................................................................................... 26 4. Construction tools ........................................................................................................................... 27 Genome-editing technologies ................................................................................................... 27 Gene synthesis technologies ..................................................................................................... 27 Biofoundries .............................................................................................................................. 27 GLOSSARY ............................................................................................................ 28 Notes .................................................................................................................................................... 30 Figures Figure 1: SynBio ingredient production with genetically modified yeast ......................................................... 6 Figure 2: Examples of different methods of obtaining vanillin ........................................................................ 9 Figure 3: Dried leaf artemisia phytomedicine .............................................................................................. 12 Figure 4: GenoCAD online platform ............................................................................................................ 26 Figure 5: Traditional vs Twist Bioscience DNA synthesis platform ............................................................... 27 Figure 6: The architecture of a typical biofoundry ....................................................................................... 28 Tables Table 1: BioTrade sectors prioritized by countries and partners ................................................................... 2 Table 2: Examples of SynBio products that could replace naturally sourced biological resources .............. 13 Acknowledgements This study was prepared by Mr. Frederic Perron-Welch, Access and Benefit-Sharing (ABS) Consultant for the BioTrade Initiative of the Trade, Environment, Climate Change and Sustainable Development Branch of UNCTAD. The study has greatly benefited from peer reviews and substantive inputs by: Ms. Lorena Jaramillo, Economic Affairs Officer, and Mr. David Vivas Eugui, Legal Officer, of the Trade, Environment, Climate Change and Sustainable Development Branch (TED) of UNCTAD; Ms. Anne Schick (Swiss State Secretariat for Economic Affairs SECO); Molly Bond (Bristol University); Dr. Marco D’Alessandro
Recommended publications
  • Glossary - Cellbiology
    1 Glossary - Cellbiology Blotting: (Blot Analysis) Widely used biochemical technique for detecting the presence of specific macromolecules (proteins, mRNAs, or DNA sequences) in a mixture. A sample first is separated on an agarose or polyacrylamide gel usually under denaturing conditions; the separated components are transferred (blotting) to a nitrocellulose sheet, which is exposed to a radiolabeled molecule that specifically binds to the macromolecule of interest, and then subjected to autoradiography. Northern B.: mRNAs are detected with a complementary DNA; Southern B.: DNA restriction fragments are detected with complementary nucleotide sequences; Western B.: Proteins are detected by specific antibodies. Cell: The fundamental unit of living organisms. Cells are bounded by a lipid-containing plasma membrane, containing the central nucleus, and the cytoplasm. Cells are generally capable of independent reproduction. More complex cells like Eukaryotes have various compartments (organelles) where special tasks essential for the survival of the cell take place. Cytoplasm: Viscous contents of a cell that are contained within the plasma membrane but, in eukaryotic cells, outside the nucleus. The part of the cytoplasm not contained in any organelle is called the Cytosol. Cytoskeleton: (Gk. ) Three dimensional network of fibrous elements, allowing precisely regulated movements of cell parts, transport organelles, and help to maintain a cell’s shape. • Actin filament: (Microfilaments) Ubiquitous eukaryotic cytoskeletal proteins (one end is attached to the cell-cortex) of two “twisted“ actin monomers; are important in the structural support and movement of cells. Each actin filament (F-actin) consists of two strands of globular subunits (G-Actin) wrapped around each other to form a polarized unit (high ionic cytoplasm lead to the formation of AF, whereas low ion-concentration disassembles AF).
    [Show full text]
  • NASA Resources for Biology Classes
    NASA Resources for Biology classes For NC Bio. Obj. 1.2.3 - Cell adaptations help cells survive in particular environments Lesson Plan: Is it Alive? This lesson is designed to be a review of the characteristics of living things. http://marsed.asu.edu/sites/default/files/stem_resources/Is_it_Alive_HS_Lesson_2_16.pdf Lesson Plan: Building Blocks of Life Experiment with Yeast to simulate carbonaceous meteorites. https://er.jsc.nasa.gov/seh/Exploring_Meteorite_Mysteries.pdf#page=138 Video: ● Subsurface Astrobiology: Cave Habitats on Earth, Mars and Beyond: In our quest to explore other planets, we only have our own planet as an analogue to the environments we may find life. By exploring extreme environments on Earth, we can model conditions that may be present on other celestial bodies and select locations to explore for signatures of life. https://images.nasa.gov/details-ARC-20160809-AAV2863-SummerSeries-15-PenelopeBoston- Youtube.html ● Real World: Heart Rate and Blood Pressure: Learn about the physiological effects reduced gravity environments have on the human body. Use multiplication to calculate cardiac output and find out what effect space travel has on sensory-motor skills, stroke volume and heart rates of the astronauts. https://nasaeclips.arc.nasa.gov/video/realworld/real-world-heart-rate-and-blood- pressure ● Launchpad: Astrobiology: Are we alone in the universe? Where do we come from? Join NASA in the search for answers to these and many more questions about life in our solar system. Learn how astrobiologists use what we know about Earth to investigate Titan, Europa and other far-off worlds. https://nasaeclips.arc.nasa.gov/video/launchpad/launchpad-astrobiology Article: ● Synthetic Biology - ‘Worker Microbes’ for Deep Space Missions https://www.nasa.gov/content/synthetic-biology For NC Bio.
    [Show full text]
  • The Principles for the Oversight of Synthetic Biology the Principles for the Oversight of Synthetic Biology
    The Principles for the Oversight of Synthetic Biology The Principles for the Oversight of Synthetic Biology Drafted through a collaborative process among civil society groups. For more information or copies of this declaration, contact: The Principles for the Eric Hoffman Food and technology policy campaigner Friends of the Earth U.S. Oversight of Synthetic Biology 1100 15th St. NW, 11th Floor Washington, D.C. 20005 202.222.0747 [email protected] www.foe.org Jaydee Hanson Policy director International Center for Technology Assessment 660 Pennsylvania Ave., SE, Suite 302 Washington, D.C. 20003 202.547.9359 [email protected] www.icta.org Jim Thomas Research program manager ETC Group 5961 Rue Jeanne Marce Montreal, Quebec Canada +1.514.273.9994 [email protected] The views expressed in this declaration represent those of the signers and do not necessarily represent those of individual contributors to Friends of the Earth U.S., International Center for Technology Assessment, ETC Group or the funding organizations. Funding thanks to CS Fund and Appleton Foundation. The Principles for the Oversight of Synthetic Biology The undersigned, a broad coalition of civil society groups, social movements, local and indigenous communities, public interest, environmental, scientif ic, human rights, religious and labor organizations concerned about various aspects of synthetic biology’s human health, environmental, social, economic, ethical and other impacts, offer the following declaration, The Principles for the Oversight of Synthetic Biology. Executive Summary Synthetic biology, an extreme form of genetic engi- and should include consideration of synthetic biology’s neering, is developing rapidly with little oversight or wide-ranging effects, including ethical, social and eco- regulation despite carrying vast uncertainty.
    [Show full text]
  • Informa Tics for Genome Analysis, Biomarkers,And Ta Rget Disco Very
    Register by March 14 and Save up to $200! Final Agenda Cambridge Healthtech Institute’s Sixth Annual April 28 – 30, 2008 • World Trade Center • Boston, MA Keynote Presentations by: Concurrent Tracks: • Informatics and IT Infrastructure & Operations • Informatics for Genome Analysis, Biomarkers, and Target Discovery Linda Avey co-Founder • Predictive and in silico Science 23andMe, Inc. • eChemistry Solutions • Clinical and Medical Informatics Joshua Boger, Ph.D. President & Chief Executive Offi cer Keynote Panel: A Must-Attend Event for the Life Vertex Pharmaceuticals, Inc. The Future of Personal Genomics: A special plenary panel discussion featuring George Church,Science Ph.D., Harvard IT Medical& Informatics School Community Dietrich Stephan, Ph.D., Navigenics John Reynders, Ph.D. Jeffrey M. Drazen, M.D., New England Journal of Medicine/Harvard Vice President & Chief Information Offi cer Medical School Johnson & Johnson, Pharma R&D Fred D. Ledley, M.D., Bentley College ...and more 2008 Benjamin Franklin Award EEventvent FFeatures:eatures: presented by Bioinformatics.org • Access All Five Tracks for One Price • Network with 1,500+ Delegates Platinum Sponsors: • Hear 85+ Technology and Scientifi c Presentations • Choose from Four Pre-conference Workshops, the Oracle Life Sciences and Healthcare User Group Meeting, and Symyx Software Symposium 2008 Gold Sponsors: • Attend Bio-IT World’s Best Practices Awards NEW Bronze Sponsor: • Connect with Attendees Using CHI’s Intro-Net Corporate Support: • Participate in the Poster Competition • See the Winners of the following 2008 Awards: Offi cial Publication: Benjamin Franklin Best of Show Lead Sponsoring Publications: Best Practices • View Who’s Who & What’s New in the Exhibit Hall • And Much More! www.Bio-ITWorldExpo.com Organized & Managed by: Cambridge Healthtech Institute 250 First Avenue, Suite 300, Needham, MA 02494 • Phone: 781-972-5400 • Fax: 781-972-5425 • Toll-free in the U.S.
    [Show full text]
  • Macromolecules of Life Worksheet
    Test Your Knowledge: Macromolecules of Life For Anatomy & Physiology I Biological Macromolecules, Fill in the blank: Macromolecule Monomer Elements Present Function Examples Carbohydrates C,H,O Lipids Fats, Oils, Phospholipids, Cholesterol, Grease, Waxes, Steroids Proteins Amino Acids Nucleic Acids Genetic Information Carbohydrates are classified by __________. The most common simple sugars are glucose, galactose and fructose that are made of a single sugar molecule. These can be classified as __________. Sucrose and __________ are classified as disaccharides; they are made of two monosaccharides joined by a dehydration reaction. The most complex carbohydrates are starch, __________ and cellulose, classified as __________. Lipids most abundant form are __________. Triglycerides building blocks are 1 __________ and 3 __________ per molecule. If a triglyceride only contains __________ bonds that contain the maximum number of __________, then it is classified as a saturated fat. If a triglyceride contains one or more __________ bonds, then it is classified as an unsaturated fat. Lipids are also responsible for a major component of the cell membrane wall that is both attracted to and repelled by water, called __________. The tail of this structure is made of 2 __________, that are water insoluble (hydrophobic). The head of this structure is made of a single __________, that is water soluble (hydrophilic). Proteins building blocks are amino acids that are held together with __________ bonds. These are covalent bonds that link the amino end of one amino acid with the carboxyl end of another. Their overall shape determines their __________. The complex 3D shape of a protein is called a __________.
    [Show full text]
  • Synthetic Biology and the CBD Five Key Decisions for COP 13 & COP-MOP 8
    Synthetic Biology and the CBD Five key decisions for COP 13 & COP-MOP 8 Synthetic biology threatens to undermine all What Is Synthetic Biology? three objectives of the Convention if Parties fail to act on the following 5 key issues: Synthetic biology describes the next generation of biotechnologies that attempt to engineer, re- 1. Operational Definition. It’s time for the design, re-edit and synthesize biological systems, CBD to adopt an operational definition of including at the genetic level. synthetic biology. Synthetic biology goes far beyond the first 2. Precaution: Gene drives. Gene drives pose generation of ‘transgenic’ engineered organisms. wide ecological and societal threats and should Predicted to be almost a 40 billion dollar (US) be placed under a moratorium. market by 2020, industrial activity in synthetic 3. Biopiracy: Digital Sequences. Synthetic biology is rapidly exploding as new genome biology allows for digital theft and use of DNA editing tools and cheaper synthesis of DNA sequences – this must be addressed by both the make it easier and faster to genetically re-design CBD and the Nagoya Protocol. or alter biological organisms. Synthetic biology-derived products already on 4. Socio-economic Impacts: Sustainable Use. the market include biosynthesized versions of The CBD needs a process to address impacts flavors, fragrances, fuels, pharmaceuticals, of synthetic biology on sustainable use of textiles, industrial chemicals, cosmetic and food biodiversity. ingredients. A next generation of synthetically 5. Cartagena Protocol: Risk Assessment. engineered (including ‘genome edited’) crops, Parties to the COP-MOP 8 need to clearly insects and animals are also nearing move forward with elaborating risk assessment commercialization.
    [Show full text]
  • Future Directions of Synthetic Biology for Energy & Power
    Future Directions of Synthetic Biology for Energy & Power March 6–7, 2018 Michael C. Jewett, Northwestern University Workshop funded by the Basic Research Yang Shao-Horn, Massachusetts Institute of Technology Office, Office of the Under Secretary of Defense Christopher A. Voigt, Massachusetts Institute of Technology for Research & Engineering. This report does not necessarily reflect the policies or positions Prepared by: Kate Klemic, VT-ARC of the US Department of Defense Esha Mathew, AAAS S&T Policy Fellow, OUSD(R&E) Preface OVER THE PAST CENTURY, SCIENCE AND TECHNOLOGY HAS BROUGHT RE- MARKABLE NEW CAPABILITIES TO ALL SECTORS OF THE ECONOMY; from telecommunications, energy, and electronics to medicine, transpor- tation and defense. Technologies that were fantasy decades ago, such as the internet and mobile devices, now inform the way we live, work, and interact with our environment. Key to this technologi- cal progress is the capacity of the global basic research community to create new knowledge and to develop new insights in science, technology, and engineering. Understanding the trajectories of this fundamental research, within the context of global challenges, em- powers stakeholders to identify and seize potential opportunities. The Future Directions Workshop series, sponsored by the Basic Re- search Directorate of the Office of the Under Secretary of Defense for Research and Engineering, seeks to examine emerging research and engineering areas that are most likely to transform future tech- nology capabilities. These workshops gather distinguished academic researchers from around the globe to engage in an interactive dia- logue about the promises and challenges of emerging basic research areas and how they could impact future capabilities.
    [Show full text]
  • Molecular Biology and Applied Genetics
    MOLECULAR BIOLOGY AND APPLIED GENETICS FOR Medical Laboratory Technology Students Upgraded Lecture Note Series Mohammed Awole Adem Jimma University MOLECULAR BIOLOGY AND APPLIED GENETICS For Medical Laboratory Technician Students Lecture Note Series Mohammed Awole Adem Upgraded - 2006 In collaboration with The Carter Center (EPHTI) and The Federal Democratic Republic of Ethiopia Ministry of Education and Ministry of Health Jimma University PREFACE The problem faced today in the learning and teaching of Applied Genetics and Molecular Biology for laboratory technologists in universities, colleges andhealth institutions primarily from the unavailability of textbooks that focus on the needs of Ethiopian students. This lecture note has been prepared with the primary aim of alleviating the problems encountered in the teaching of Medical Applied Genetics and Molecular Biology course and in minimizing discrepancies prevailing among the different teaching and training health institutions. It can also be used in teaching any introductory course on medical Applied Genetics and Molecular Biology and as a reference material. This lecture note is specifically designed for medical laboratory technologists, and includes only those areas of molecular cell biology and Applied Genetics relevant to degree-level understanding of modern laboratory technology. Since genetics is prerequisite course to molecular biology, the lecture note starts with Genetics i followed by Molecular Biology. It provides students with molecular background to enable them to understand and critically analyze recent advances in laboratory sciences. Finally, it contains a glossary, which summarizes important terminologies used in the text. Each chapter begins by specific learning objectives and at the end of each chapter review questions are also included.
    [Show full text]
  • The Structure and Function of Large Biological Molecules 5
    The Structure and Function of Large Biological Molecules 5 Figure 5.1 Why is the structure of a protein important for its function? KEY CONCEPTS The Molecules of Life Given the rich complexity of life on Earth, it might surprise you that the most 5.1 Macromolecules are polymers, built from monomers important large molecules found in all living things—from bacteria to elephants— can be sorted into just four main classes: carbohydrates, lipids, proteins, and nucleic 5.2 Carbohydrates serve as fuel acids. On the molecular scale, members of three of these classes—carbohydrates, and building material proteins, and nucleic acids—are huge and are therefore called macromolecules. 5.3 Lipids are a diverse group of For example, a protein may consist of thousands of atoms that form a molecular hydrophobic molecules colossus with a mass well over 100,000 daltons. Considering the size and complexity 5.4 Proteins include a diversity of of macromolecules, it is noteworthy that biochemists have determined the detailed structures, resulting in a wide structure of so many of them. The image in Figure 5.1 is a molecular model of a range of functions protein called alcohol dehydrogenase, which breaks down alcohol in the body. 5.5 Nucleic acids store, transmit, The architecture of a large biological molecule plays an essential role in its and help express hereditary function. Like water and simple organic molecules, large biological molecules information exhibit unique emergent properties arising from the orderly arrangement of their 5.6 Genomics and proteomics have atoms. In this chapter, we’ll first consider how macromolecules are built.
    [Show full text]
  • Research Laboratory of Electronics
    Research Laboratory of Electronics The Research Laboratory of Electronics (RLE) at MIT is a vibrant intellectual community and was one of the Institute’s earliest modern interdepartmental academic research centers. RLE research encompasses both basic and applied science and engineering in an extensive range of natural and man-made phenomena. Integral to RLE’s efforts is the furthering of scientific understanding and leading innovation to provide great service to society. The lab’s research spans the fundamentals of quantum physics and information theory to synthetic biology and power electronics and extends to novel engineering applications, including those that produce significant advances in communication systems or enable remote sensing from aircraft and spacecraft, and the development of new biomaterials and innovations in diagnostics and treatment of human diseases. RLE was founded in 1946 following the groundbreaking research that led to the development of ultra-high-frequency radar, a technology that changed the course of World War II. It was home to some of the great discoveries made in the 20th century at MIT. Cognizant of its rich history and focus on maintaining its position as MIT’s leading interdisciplinary research organization, RLE fosters a stimulating and supportive environment for innovative research and impact. What distinguishes RLE today from all other entities at MIT is its breadth of intellectual pursuit and diversity of research themes. The lab supports its researchers by providing a wide array of services spanning financial and human resources (HR), information technology, and renovations. It is fiscally independent and maintains a high level of loyalty from its principal investigators (PIs) and staff.
    [Show full text]
  • Synthetic Biology an Overview of the Debates
    SYNTHETIC BIOLOGY PROJECT / SYNBIO 3 SYNTHETIC BIOLOGY Ethical Issuesin SYNBIO 3/JUNE2009 An overview ofthedebates Contents Preface 3 Executive Summary 4 Who is doing what, where are they doing it and how is this current work funded? 6 How distinct is synthetic biology from other emerging areas of scientific and technological innovation? 9 Ethics: What harms and benefits are associated with synthetic biology? 12 The pro-actionary and pre-cautionary frameworks 18 N OVERVIEW OF THE DEBATES N OVERVIEW OF A Competing—and potentially complementary—views about non-physical harms (harms to well-being) 23 The most contested harms to well-being 25 Conclusion: Moving the debate forward 26 References 29 ETHICAL ISSUES IN SYNTHETIC BIOLOGY: ETHICAL ISSUES IN SYNTHETIC BIOLOGY: ii The opinions expressed in this report are those of the authors and do not necessarily reflect views Sloan Foundation. Wilson International Center for Scholars or the Alfred P. of the Woodrow Ethical Issues in SYNTHETIC BIOLOGY An overview of the debates Erik Parens, Josephine Johnston, and Jacob Moses The Hastings Center, Garrison, New York SYNBIO 3 / JUNE 2009 2 ETHICAL ISSUES IN SYNTHETIC BIOLOGY: AN OVERVIEW OF THE DEBATES Preface Synthetic biology will allow scientists and where such topics are divided into two broad engineers to create biological systems categories: concerns about physical and non- that do not occur naturally as well as to physical harms. While physical harms often re-engineer existing biological systems to trigger debates about how to proceed among perform novel and beneficial tasks. This researchers, policymakers, and the public, emerging field presents a number of non-physical harms present more difficult opportunities to address ethical issues early conundrums.
    [Show full text]
  • Genome Mining and Synthetic Biology in Marine Natural Product Discovery
    marine drugs Editorial Genome Mining and Synthetic Biology in Marine Natural Product Discovery Maria Costantini Department of Marine Biotechnology, Stazione Zoologica Anton Dohrn, Villa Comunale, 80121 Napoli, Italy; [email protected]; Tel.: +39-081-583-3285 Received: 17 November 2020; Accepted: 22 November 2020; Published: 3 December 2020 Oceans cover nearly 70% of the earth’s surface and host a huge ecological, chemical, and biological diversity. The natural conditions of the sea favor, in marine organisms, the production of a large variety of novel molecules with great pharmaceutical potential. Marine organisms are unique in their structural and functional features compared to terrestrial ones [1,2]. Innovation in this field is very rapid, as revealed by the funding of several Seventh Framework Programme (FP7) and Horizon 2020 projects under the topic “Blue Growth”. The major parts of these projects have the common final goal of meeting the urgent need to discover new drug entities to counteract the increased incidence of severe diseases (such as cancer) and the reduced efficacy of existing drugs [3]. For this reason, the application of molecular biology techniques in biotechnological field is very important. Driven by the rapidly-decreasing cost and increasing throughput of DNA-sequencing technologies, significant progress in genomics has renewed interest in the discovery of natural products. Rapidly-expanding genomic and metagenomic datasets reveal a vast number of biosynthetic gene clusters (BGCs) in nature, which are predicted to encode novel biomedically-relevant molecules. This ‘top-down’ discovery approach can only provide access to a small fraction of biosynthetic compounds, given that the majority of microorganisms cannot be isolated or cultured.
    [Show full text]